Metabolic disease companies develop therapies, diagnostics and research technologies for disorders affecting how the body processes and stores energy. Their work spans diabetes, obesity, fatty liver disease and inherited metabolic conditions.
This category includes companies working on:
Browse 46 UK metabolic disease companies below.
Oral muscle-sparing small molecule therapies for obesity
Hawkhill Therapeutics is a pre-clinical biotechnology company developing oral, muscle-sparing therapeutics for obesity and metabolic health. Its programme targets a clinically…
Blood-based liquid biopsy for endothelial glycocalyx and microvascular health
Dimension Biotechnologies is a biotech developing a rapid, blood-based diagnostic for microvascular health based on analysis of the endothelial glycocalyx, the molecular layer…
Synthetic glucose-binding molecules for continuous glucose monitoring
Carbometrics Limited is a supramolecular chemistry biotech developing synthetic Glucose Binding Molecules (GBMs) for use in continuous glucose monitoring sensors and other…
GC-IMS analytical instruments for clinical, food and environmental testing
Imspex Diagnostics is a Welsh analytical instruments company developing and distributing Gas Chromatography-Ion Mobility Spectrometry platforms for clinical diagnostics, food…
Genomics platform developing RNA therapies for chronic liver disease
Ochre Bio is a biotechnology company developing RNA therapeutics for chronic liver disease using a platform built on large-scale human liver datasets. The platform integrates gene…
Circadian hormone therapeutics for rare endocrine conditions
Neurocrine UK is the European operations of Neurocrine Biosciences, a Cardiff-headquartered specialty pharmaceutical company developing and commercialising hormone therapeutics…
DNA-based gene therapy platform for intercellular therapeutic gene delivery
Bitrobius Genetics is a UK biotech developing a novel DNA-based gene therapy platform technology designed to deliver functional copies of mutated genes to cells within a target…
Global diabetes and cardiometabolic medicines leader
Novo Nordisk Limited is the UK commercial and medical affiliate of Novo Nordisk A/S, the Danish pharmaceutical company focused on diabetes, obesity, and cardiometabolic disease.…
Diagnostics, devices and diabetes care for global healthcare
Abbott Laboratories is a multinational healthcare company providing diagnostic instruments, reagents, and medical devices to hospitals, laboratories, and healthcare professionals.…
Novel peptide therapeutics targeting obesity and type 2 diabetes
Dia Beta Labs is a preclinical-stage biotechnology company developing first-in-class therapeutic peptides for metabolic disease. Spun out of the Diabetes Research Group at Ulster…
Antigenic immunomodulation therapies targeting autoimmune disease
Phaim Pharma is a biotech company developing disease-modifying therapeutics for autoimmune conditions using its proprietary platform. The platform is designed to reset the immune…
AI-powered RNAi drug discovery company developing hepatic medicines
Tangram Therapeutics is a biotechnology company combining artificial intelligence and RNA interference to discover and develop novel medicines. Its proprietary chemistry platform…